Review of Article: Yahyavi et al. Benefits of glucagon-like peptide (GLP)-1 receptor agonists on 5-year risk of major amputation, all-cause mortality, myocardial infarction, and ischemic stroke in patients with chronic limb-threatening ischemia. Vasc Med. 2026;31(1):719–727
Review of Article: Yahyavi et al. Benefits of glucagon-like peptide (GLP)-1 receptor agonists on 5-year risk of major amputation, all-cause mortality, myocardial infarction, and ischemic stroke in patients with chronic limb-threatening ischemia. Vasc Med. 2026;31(1):719–727. // Journal of Vascular Nursing. – URL: https://www.sciencedirect.com/science/article/pii/S106203032600049X?dgcid=rss_sd_all
Review of Article: Yahyavi et al. Benefits of glucagon-like peptide (GLP)-1 receptor agonists on 5-year risk of major amputation, all-cause mortality, myocardial infarction, and ischemic stroke in patients with chronic limb-threatening ischemia. Vasc Med. 2026;31(1):719–727. Journal of Vascular Nursing. https://www.sciencedirect.com/science/article/pii/S106203032600049X?dgcid=rss_sd_all
“Review of Article: Yahyavi et al. Benefits of glucagon-like peptide (GLP)-1 receptor agonists on 5-year risk of major amputation, all-cause mortality, myocardial infarction, and ischemic stroke in patients with chronic limb-threatening ischemia. Vasc Med. 2026;31(1):719–727.” Journal of Vascular Nursing.
@article{article56427,
title = {Review of Article: Yahyavi et al. Benefits of glucagon-like peptide (GLP)-1 receptor agonists on 5-year risk of major amputation, all-cause mortality, myocardial infarction, and ischemic stroke in patients with chronic limb-threatening ischemia. Vasc Med. 2026;31(1):719–727},
journal = {Journal of Vascular Nursing},
url = {https://www.sciencedirect.com/science/article/pii/S106203032600049X?dgcid=rss_sd_all}
}